SCHEMBL752407

SCHEMBL752407

Cc1cc(Cl)ccc1S(=O)(=O)C(I)I

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.46
TRPV4 Q9HBA0 1/20 0.40
NPSR1 Q6W5P4 1/20 0.37
FLT1 P17948 1/20 0.36
FLT4 P35916 1/20 0.36
KDR P35968 1/20 0.36
CDK1 P06493 1/20 0.36
CCNB1 P14635 1/20 0.36
CCNA2 P20248 1/20 0.36
CDK2 P24941 1/20 0.36
CDK7 P50613 1/20 0.36
CCNH P51946 1/20 0.36
CCNA1 P78396 1/20 0.36
TSHR P16473 1/20 0.36
HTR2A P28223 1/20 0.36
HTR2C P28335 1/20 0.36
HTR2B P41595 1/20 0.36
CYP3A4 P08684 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
CCR2 P41597 3/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3687664 0.81 ALDH1A1 (0.44) GAAL3MBTL1ALDH1A1
SCHEMBL251514 0.78 GAA (0.62) GAATRPV4NPSR1FLT1FLT4
SCHEMBL2122763 0.78 GAA (0.62) GAATRPV4NPSR1FLT1FLT4
SCHEMBL751573 0.78 ALDH1A1 (0.42) GAATSHRCYP3A4L3MBTL1ALDH1A1
SCHEMBL753254 0.78 CA1 (0.49) NPSR1FLT1FLT4KDRL3MBTL1
SCHEMBL29948957 0.76 TRPV4 (0.58) GAATRPV4NPSR1FLT1FLT4
SCHEMBL1199760 0.76 TRPV4 (0.58) GAATRPV4NPSR1FLT1FLT4
SCHEMBL8405133 0.76 L3MBTL1 (0.59) GAATRPV4NPSR1FLT1FLT4
SCHEMBL31501416 0.75 PDIA6 (0.51) GAATRPV4FLT1FLT4KDR
SCHEMBL4501445 0.75 GAA (0.50) GAATRPV4FLT1FLT4KDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2213166-B1 Biocidal compounds containing 2-methylisothiazolin-3-one and a haloalkylsulfone THOR GMBH (DE) 2012-03-21 EP claimed
US-20100189811-A1 Biocide compositions comprising 3-methylisothiazolin-3-one and a haloalkyl sulphone THOR GMBH (DE) 2010-07-29 US claimed
US-8287631-B2 Compounds for preventing ghost odour THOR GMBH (DE) 2012-10-16 US disclosed
US-20100189811-A1 Biocide compositions comprising 3-methylisothiazolin-3-one and a haloalkyl sulphone THOR GMBH (DE) 2010-07-29 US disclosed
US-20100186631-A1 Compounds for preventing ghost odour THOR GMBH (DE) 2010-07-29 US disclosed
US-4018611-A Non-yellowing antimicrobial compositions comprising diiodomethyl sulfones METALORGANA ETABLISSEMENT (FL) 1977-04-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100189811-A1 Biocide compositions comprising 3-methylisothiazolin-3-one and a haloalkyl sulphone MBTD1, MPST, B2M GAA 3827/4885TRPV4 718/4885NPSR1 3666/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.